Instil Bio, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was USD 58.99 million compared to USD 35.31 million a year ago. Basic loss per share from continuing operations was USD 0.46 compared to USD 0.27 a year ago.
For the six months, net loss was USD 113.11 million compared to USD 58.44 million a year ago. Basic loss per share from continuing operations was USD 0.88 compared to USD 0.71 a year ago.